A Study for those with Treatment Resistant Epilepsy & Anxiety

Official Title
An open-label clinical trial evaluating the ExAblate Model 4000 Type-1 focused ultrasound unilateral thalamotomy for patients with treatment-refractory focal onset epilepsy and comorbid anxiety

The purpose of the study is to learn more about whether an ultrasound treatment for epilepsy and anxiety is safe and effective.

Could this study be right for you?
  • Age: 18-65 years old
  • Treatment resistant Epilepsy (focal or partial-onset seizures)
  • ≥ 3 seizures/month
  • Moderate-to-severe Anxiety



Age Range
18 - 65 years